TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,419,000 | -63.4% | 77,956 | -67.1% | 0.03% | -57.1% |
| Q3 2021 | $3,878,000 | -2.1% | 236,770 | +0.6% | 0.08% | -1.3% |
| Q2 2021 | $3,961,000 | +178.9% | 235,338 | +202.6% | 0.08% | +136.4% |
| Q1 2021 | $1,420,000 | +0.1% | 77,780 | -0.2% | 0.03% | -5.7% |
| Q4 2020 | $1,419,000 | -9.3% | 77,955 | -11.2% | 0.04% | -20.5% |
| Q3 2020 | $1,565,000 | -7.5% | 87,739 | -7.0% | 0.04% | -15.4% |
| Q2 2020 | $1,692,000 | +8.8% | 94,366 | -7.9% | 0.05% | -7.1% |
| Q1 2020 | $1,555,000 | -31.0% | 102,448 | -10.2% | 0.06% | -15.2% |
| Q4 2019 | $2,252,000 | -22.0% | 114,130 | -32.0% | 0.07% | -28.3% |
| Q3 2019 | $2,887,000 | -21.2% | 167,871 | -18.9% | 0.09% | -20.7% |
| Q2 2019 | $3,665,000 | -26.1% | 207,113 | -15.0% | 0.12% | -26.1% |
| Q1 2019 | $4,962,000 | – | 243,589 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |